TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

DSpace/Manakin Repository

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

Citable link to this page


Title: TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Author: Remke, Marc; Ramaswamy, Vijay; Peacock, John; Shih, David J. H.; Koelsche, Christian; Northcott, Paul A.; Hill, Nadia; Cavalli, Florence M. G.; Kool, Marcel; Wang, Xin; Mack, Stephen C.; Barszczyk, Mark; Morrissy, A. Sorana; Wu, Xiaochong; Agnihotri, Sameer; Luu, Betty; Jones, David T. W.; Garzia, Livia; Dubuc, Adrian M.; Zhukova, Nataliya; Vanner, Robert; Kros, Johan M.; French, Pim J.; Van Meir, Erwin G.; Vibhakar, Rajeev; Zitterbart, Karel; Chan, Jennifer A.; Bognár, László; Klekner, Almos; Lach, Boleslaw; Jung, Shin; Saad, Ali G.; Liau, Linda M.; Albrecht, Steffen; Zollo, Massimo; Cooper, Michael K.; Thompson, Reid C.; Delattre, Oliver O.; Bourdeaut, Franck; Doz, François F.; Garami, Miklós; Hauser, Peter; Carlotti, Carlos G.; Van Meter, Timothy E.; Massimi, Luca; Fults, Daniel; Pomeroy, Scott L.; Kumabe, Toshiro; Ra, Young Shin; Leonard, Jeffrey R.; Elbabaa, Samer K.; Mora, Jaume; Rubin, Joshua B.; Cho, Yoon-Jae; McLendon, Roger E.; Bigner, Darell D.; Eberhart, Charles G.; Fouladi, Maryam; Wechsler-Reya, Robert J.; Faria, Claudia C.; Croul, Sidney E.; Huang, Annie; Bouffet, Eric; Hawkins, Cynthia E.; Dirks, Peter B.; Weiss, William A.; Schüller, Ulrich; Pollack, Ian F.; Rutkowski, Stefan; Meyronet, David; Jouvet, Anne; Fèvre-Montange, Michelle; Jabado, Nada; Perek-Polnik, Marta; Grajkowska, Wieslawa A.; Kim, Seung-Ki; Rutka, James T.; Malkin, David; Tabori, Uri; Pfister, Stefan M.; Korshunov, Andrey; von Deimling, Andreas; Taylor, Michael D.

Note: Order does not necessarily reflect citation order of authors.

Citation: Remke, M., V. Ramaswamy, J. Peacock, D. J. H. Shih, C. Koelsche, P. A. Northcott, N. Hill, et al. 2013. “TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.” Acta Neuropathologica 126 (1): 917-929. doi:10.1007/s00401-013-1198-2. http://dx.doi.org/10.1007/s00401-013-1198-2.
Full Text & Related Files:
Abstract: Telomerase reverse transcriptase (TERT) promoter mutations were recently shown to drive telomerase activity in various cancer types, including medulloblastoma. However, the clinical and biological implications of TERT mutations in medulloblastoma have not been described. Hence, we sought to describe these mutations and their impact in a subgroup-specific manner. We analyzed the TERT promoter by direct sequencing and genotyping in 466 medulloblastomas. The mutational distributions were determined according to subgroup affiliation, demographics, and clinical, prognostic, and molecular features. Integrated genomics approaches were used to identify specific somatic copy number alterations in TERT promoter-mutated and wild-type tumors. Overall, TERT promoter mutations were identified in 21 % of medulloblastomas. Strikingly, the highest frequencies of TERT mutations were observed in SHH (83 %; 55/66) and WNT (31 %; 4/13) medulloblastomas derived from adult patients. Group 3 and Group 4 harbored this alteration in <5 % of cases and showed no association with increased patient age. The prognostic implications of these mutations were highly subgroup-specific. TERT mutations identified a subset with good and poor prognosis in SHH and Group 4 tumors, respectively. Monosomy 6 was mostly restricted to WNT tumors without TERT mutations. Hallmark SHH focal copy number aberrations and chromosome 10q deletion were mutually exclusive with TERT mutations within SHH tumors. TERT promoter mutations are the most common recurrent somatic point mutation in medulloblastoma, and are very highly enriched in adult SHH and WNT tumors. TERT mutations define a subset of SHH medulloblastoma with distinct demographics, cytogenetics, and outcomes. Electronic supplementary material The online version of this article (doi:10.1007/s00401-013-1198-2) contains supplementary material, which is available to authorized users.
Published Version: doi:10.1007/s00401-013-1198-2
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830749/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879110
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search